ArticleCancer research2014

CDK4/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancers.

Andreas M Heilmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.